Background: Considering a dramatic increase in the incidence of type 1 diabetes (T1D) worldwide, current research focuses on complex etiology of T1D where immune system, environmental and genetic factors play a significant role. Glutathione S-transferase family of enzymes protects tissue from oxidative damage which is discussed in the context of T1D. The aim of the study was to investigate an association of glutathione S-transferase mu 1 (GST M1) and glutathione S-transferase theta 1 (GST T1) polymorphisms with type 1 diabetes.
INTRODUCTION
Epidemiological studies indicate that the incidence and prevalence of type 1 diabetes mellitus (T1D) is rising worldwide. The incidence rate of childhood T1D across Europe rises nonuniformly every year by an average of 3-4% (1) . In Slovakia, a 2.57-fold increase in the incidence of T1D from 1986 to 1998 was the highest among children 10-14 years of age and increased dramatically especially in children 0-4 years old (2) . Although significant effort has been made to improve the quality of life and clinical outcomes in patients with T1D, much more needs to be done to find the prevention and cure of T1D. Therefore, research of risk factors of T1D is necessary to identify triggers that could potentially be targeted for intervention. Current studies focus on predisposing factors in complex etiology of T1D, where immune system, environmental triggers and genetic susceptibility play a significant role. One of the pathways discussed in the etiopathogenesis of T1D is oxidative stress (3) characterized as an imbalance between reactive oxygen species (ROS) production and antioxidant mechanisms. ROS are liberated by activated macrophages and T lymphocytes and are induced by proinflammatory cytokines involved in autoimmune process of pancreatic beta cells. An increased level of ROS causes oxidative modification of proteins and nucleic acids and lipid peroxidation. These changes may result in alteration in biological functions of all biomolecules, in metabolism of all tissues and cell damage including beta cells.
Glutathione S-transferase (GST) represents a family of enzymes catalyzing the conjugation of glutathione with various electrophilic compounds to facilitate their excretion (4). The broad substrate specificity of GSTs allows them to protect cells against a range of toxic chemicals, however, this GST activity can be deleterious in certain cases, as it can cause chemotherapy resistance or the arisen metabolite can be more toxic than the primary molecule (5) . GST enzymes are involved in the synthesis of inflammatory mediators, leukotrienes and prostaglandins and act also in cell signaling pathway as potential regulators of apoptosis. Regarding their function within oxidative stress, GSTs detoxify some of the secondary ROS generated during oxidation of membranes or other cellular constituents. GSTs act in the detoxification of organic hydroperoxides and protect cells from peroxide-induced cell death (6) .
According to substrate specificity, chemical affinity, structure, sequence, and kinetic behaviour, few classes of soluble GSTs have been identified (alpha, kappa, mu, pi, theta, zeta, omega, and sigma). The most researched one is glutathione S-transferase mu 1 (GST M1) enzyme in GST M class with its gene located in Chromosome 1p13.3 and glutathione S-transferase theta 1 (GST T1) enzyme in GST T class with its gene located in Chromosome 22q11.23. It has been shown that individuals carrying the null genotype of GST have significantly reduced activity of this enzyme compared to wild genotype carriers (7) .
According to recent studies, GST T1 and M1 are regarded as candidate polymorphisms for susceptibility to type 2 diabetes (T2D) (8) or chronic diabetic complications (9) . The majority of studies have focused on adult subjects with T2D, only one collective of authors has targeted young subjects with T1D (10) . The aim of this study was to determine the association between T1D and GST T1 and M1 gene polymorphisms in Slovak children and adolescents.
MATERIALS AND METHODS

Study Subjects and Studied Parameters
The study was approved by the Ethical Committee of Jessenius Faculty of Medicine in Martin, Slovakia, in accordance with the ethical standards. 163 enrolled subjects, at the age 6-19 years, and their legal representatives were informed about the aim of the study and signed informed consent. The study group was represented by 116 patients with T1D (53 females, 63 males, average age 12.95±4.13 years, average diabetes duration 5.00±3.97 years), diagnosis based on criteria of the American Diabetes Association (11) . The control group was represented by 47 healthy volunteers (25 females, 22 males, average age 13.98±3.32 years) with matched age and sex in which diabetes mellitus, obesity, cardiovascular, respiratory, and nervous diseases were excluded.
Information about duration and onset of diabetes in subjects with T1D and basic anthropometric parameters -height, weight and body mass index (BMI) in each subject were obtained. Basic biochemical parameters -glucose, glycosylated hemoglobin, cholesterol, triacylglycerol, bilirubin, uric acid, and creatinine were established from blood sample in each child.
DNA Extraction and Polymorphism Detection
Genomic DNA was extracted from peripheral venous blood using standard phenol -chloroform method. GST T1 and M1 genetic polymorphisms were evaluated using the multiplex polymerase chain reaction (PCR) technique. Primers for GST M1 polymorphisms were 5´-GAACTCCCTGAAAAGCTAAAGC-3´ and 5´-GTTGGGCTCAAATATACGGTGG-3´ and for GST T1 5´-TTCGTTACTGGTCCTCACATCTC-3´ and 5´-TCACG-GGATCATGGCCAGCA-3´. The beta-globin was used as a locus control to avoid false-negative readings. Primers for beta-globin were 5´-CAACTTCATCCACGTTCACC-3´and 5´-GAAGAGCCAAGGACAGGTAC-3´. The PCR products were electrophoresed in agarose gel and visualized by ethidium bromide staining. The length of products was 215 bp, 480 bp and 268 bp for GST M1, GST T1 and beta-globin, respectively.
Statistical Analysis
The results were processed by statistic program SYSTAT (version 11). The observed parameters were expressed as mean ± standard error (SE). Students' t-test was used to assess significant difference between subgroups and p<0.05 was considered statistically significant. Genotype frequencies were compared using chi-square (χ 2 ) test. Odds ratio (OR) with 95% confidence interval (95% CI) calculated by logistic regression was used to describe the strength of association. 
RESULTS
Characteristics of Diabetic and Control Subjects
GST T1 and M1 Gene Polymorphisms in Diabetic and Control Subjects
The frequency of GST T1 null genotype was 36.2% in the diabetic group and 21.3% in the control group. It represented 2.1-fold increased risk of T1D, however, this finding was of borderline statistical significance (OR=2.1; 95% CI=0.949-4.648; p=0.064). No significant difference was found in GST M1 genotypes between diabetic and healthy subjects (Table 2) , the frequency of GST M1 null genotype was 39.7% and 40.4%, respectively. Double analysis of GST genotypes revealed that T1D patients had significantly more frequent occurrence of GST T1 null/ M1 wild genotype compared to the healthy controls (25.9% vs. 10.6%, respectively) and this combination of alleles 2.9-times increased the risk of T1D (OR=2.93; 95% CI=1.061-8.095; χ 2 =4.6; p=0.032). GST T1 null/M1 null genotype as well as other genotype combinations did not show the significant difference (Table 3) .
DISCUSSION
GST T1 and M1 polymorphisms were supposed to have an influence on pathogenesis of numerous conditions like allergy, bronchial asthma, coronary artery disease, cancer, or hypertension (12-16). As GSTs are involved in the detoxification of secondary ROS and in synthesis of proinflammatory mediators, both contributing to pancreatic beta cell damage, we hypothesize that GST polymorphisms may play role in the etiology of T1D.
We observed that GST T1 null genotype was more frequent in subjects with T1D compared to the healthy children, and represented 2.1-fold increased risk of T1D of borderline statistical significance. Genotype combination GST T1 null/M1 wild was significantly more prevalent in subjects with diabetes and represented 2.9-fold risk for T1D developing. The majority of studies on GST T1/M1 gene polymorphisms have reported that null genotypes represented an increased risk of the disease (8, 9, (13) (14) (15) . It may be explained by the fact that carriers of GST null genotype have significantly lower activity of this antioxidant enzyme (7) . Only one collective of authors has reported that null genotype is associated with disease protection (10) , it may be explained by several speculative possibilities. First, the absence of GST may upregulate other antioxidant genes like superoxide dismutase (17) . Second, GST enzymes are normally involved in the synthesis of inflammatory mediators, leukotrienes and prostaglandins (4), so lack of GST activity may lead to decrease in the inflammatory response and to protection against T1D. Third, an unknown compound may be metabolized by GST into a toxic form, so null genotype would be protective, such as dihaloalkanes are bioactivated by increased activity of GST T1 into more genotoxic metabolites (5) or GST pi knockout mice are protected against acetaminophen toxicity as acetaminophen is not activated into its toxic metabolite (18) .
To the best of our knowledge, only one study deals with GST polymorphisms and diabetes susceptibility in patients with T1D, till now. In the young Swedish population, no association was found regarding GST T1 genotype. GST M1 wild genotype was associated with a higher risk of T1D in the group of 14-20 years old subjects and GST M1 null genotype was regarded as protective (10) . Similarly to Bekris et al., we claim that GST M1 wild increases the risk of T1D, however, in our study not itself but in combination with GST T1 null allele. This discrepancy may be n -number of subjects; p -statistic probability; OR -odds ratio; CI -confidence interval caused by different geographical area and studied population. Probably, insufficient antioxidant activity due to GST T1 null allele together with one of the speculative possibilities due to GST M1 wild allele represent the risk factor for Slovak subjects with T1D. We acknowledge that the number of our subjects, especially in the control group, is not extensive, however, these results could be useful considering the few studies dealing with the same topic. Moreover, the presence of polymorphisms is comparable with other published works. The prevalence of GST T1 null genotype was 21.3% in our control group and 20.4% in the Caucasian population (19) . GST M1 null genotype was present with a frequency of 40.4% in our control subjects, compared to 38-62% in European countries (20) . In our study, subjects with diabetes had significantly lower concentration of uric acid compared to the controls. As uric acid is considered to be an antioxidant, this result can indicate lower antioxidant status or increased consumption of uric acid due to oxidative stress in subjects with diabetes. Uric acid is also considered to be a marker of metabolic syndrome (21) , however, in our study other markers of metabolic syndrome (cholesterol, triacylglycerol and BMI) did not show the same tendency. Finally, the uric acid is one of the nitrogen compounds excreted by kidneys. Its lower concentration could be explained by hyperfiltration of kidneys as the early diabetic complication which is enhanced by the finding of the same creatinine concentration trend.
To sum up, imbalance between ROS production and antioxidant mechanisms as well as gene polymorphisms of GSTs, enzymes with various functions may contribute to T1D development. Our results suggest that gene polymorphisms of antioxidant enzyme glutathione S-transferase may play a partial role in pathogenesis of type 1 diabetes. GST T1 null genotype and combination GST T1 null/M1 wild can be regarded as the risk factors for T1D development in children and adolescents in the Slovak population. Further investigations with extended number of subjects are needed to clarify these associations.
